Transformation and Metastasis
CLINICAL RESEARCHERS
- Maria Teresa Soler Monsó
- Andrea Carolina Vethencourt Casado
POSTDOCTORAL RESEARCHERS (R2)
- Eva Maria Trinidad Alvarez
- Ana Sofia Semiao Da Rocha
PREDOCTORAL RESEARCHERS (R1)
- Clara Gomez Aleza
SCIENTIFIC SUPPORT
- Manuel Gris Lorente
CANCER
Cancer Epigenetics and Biology
Scientific production
5
PAPERS
Impact factor: 23,943
1 PUBLICATIONS IN FIRST DECILE
2 PUBLICATIONS IN FIRST QUARTILE
Selected publications
- Gomez-Aleza, Clara; Nguyen, Bastien; Yoldi, Guillermo; Ciscar, Marina; Barranco, Alexandra; Hernandez-Jimenez, Enrique; Maetens, Marion; Salgado, Roberto; Zafeiroglou, Maria; Pellegrini, Pasquale; Venet, David; Garaud, Soizic; Trinidad, Eva M.; Benitez, Sandra; Vuylsteke, Peter; Polastro, Laura; Wildiers, Hans; Simon, Philippe; Lindeman, Geoffrey; Larsimont, Denis; Van den Eynden, Gert; Velghe, Chloe; Rothe, Francoise; Willard-Gallo, Karen; Michiels, Stefan; Munoz, Purificacion; Walzer, Thierry; Planelles, Lourdes; Penninger, Josef; Azim, Hatem A., Jr.; Loi, Sherene; Piccart, Martine; Sotiriou, Christos; Gonzalez-Suarez, Eva. Inhibition of RANK signaling in breast cancer induces an anti-tumor immune response orchestrated by CD8+T cells. NATURE COMMUNICATIONS. 10.1038/s41467-020-20138-8
- Kos, Zuzana; Roblin, Elvire; Kim, Rim S.; Michiels, Stefan; Gallas, Brandon D.; Chen, Weijie; van de Vijver, Koen K.; Goel, Shom; Adams, Sylvia; Demaria, Sandra; Viale, Giuseppe; Nielsen, Torsten O.; Badve, Sunil S.; Symmans, W. Fraser; Sotiriou, Christos; Rimm, David L.; Hewitt, Stephen; Denkert, Carsten; Loibl, Sibylle; Luen, Stephen J.; Bartlett, John M. S.; Savas, Peter; Pruneri, Giancarlo; Dillon, Deborah A.; Cheang, Maggie Chon U.; Tutt, Andrew; Hall, Jacqueline A.; Kok, Marleen; Horlings, Hugo M.; Madabhushi, Anant; van der Laak, Jeroen; Ciompi, Francesco; Laenkholm, Anne-Vibeke; Bellolio, Enrique; Gruosso, Tina; Fox, Stephen B.; Araya, Juan Carlos; Floris, Giuseppe; Hudecek, Jan; Voorwerk, Leonie; Beck, Andrew H.; Kerner, Jen; Larsimont, Denis; Declercq, Sabine; Van den Eynden, Gert; Pusztai, Lajos; Ehinger, Anna; Yang, Wentao; AbdulJabbar, Khalid; Yuan, Yinyin; Singh, Rajendra; Hiley, Crispin; al Bakir, Maise; Lazar, Alexander J.; Naber, Stephen; Wienert, Stephan; Castillo, Miluska; Curigliano, Giuseppe; Dieci, Maria-Vittoria; Andre, Fabrice; Swanton, Charles; Reis-Filho, Jorge; Sparano, Joseph; Balslev, Eva; Chen, I-Chun; Stovgaard, Elisabeth Ida Specht; Pogue-Geile, Katherine; Blenman, Kim R. M.; Penault-Llorca, Frederique; Schnitt, Stuart; Lakhani, Sunil R.; Vincent-Salomon, Anne; Rojo, Federico; Braybrooke, Jeremy P.; Hanna, Matthew G.; Soler-Monso, M. Teresa; Bethmann, Daniel; Castaneda, Carlos A.; Willard-Gallo, Karen; Sharma, Ashish; Lien, Huang-Chun; Fineberg, Susan; Thagaard, Jeppe; Comerma, Laura; Gonzalez-Ericsson, Paula; Brogi, Edi; Loi, Sherene; Saltz, Joel; Klaushen, Frederick; Cooper, Lee; Amgad, Mohamed; Moore, David A.; Salgado, Roberto. Pitfalls in assessing stromal tumor infiltrating lymphocytes (sTILs) in breast cancer. NPJ BREAST CANCER. 10.1038/s41523-020-0156-0
- Garcia-Tejedor, Amparo; Fernandez-Gonzalez, Sergi; Ortega, Raul; Gil-Gil, Miguel; Perez-Montero, Hector; Fernandez-Montoli, Eulalia; Stradella, Agostina; Recalde, Sabela; Soler, Teresa; Petit, Anna; Bajen, Maria Teresa; Benitez, Ana; Guma, Anna; Campos, Miriam; Pla, Maria J.; Martinez, Evelyn; Laplana, Maria; Pernas, Sonia; Perez-Sildekova, Diana; Catala, Isabel; Ponce, Jordi; Falo, Catalina. Can we avoid axillary lymph node dissection in N2 breast cancer patients with chemo-sensitive tumours such as HER2 and TNBC?. BREAST CANCER RESEARCH AND TREATMENT. 10.1007/s10549-020-05970-2
- Fernandez-Gonzalez S., Falo C., Pla M.J., Verdaguer P., Nuñez D., Guma A., Soler T., Vethencourt A., Vázquez S., Fernandez-Montoli M.E., Campos M., Pernas S., Gil M., Ponce J., Garcia-Tejedor A.. Predictive factors for omitting lymphadenectomy in patients with node-positive breast cancer treated with neo-adjuvant systemic therapy. BREAST JOURNAL. 10.1111/tbj.13763
- Nettleton, David F.; Estivill-Castro, Vladimir; Hernandez Jimenez, Enrique. Multi-agent Modeling Simulation of In-vitro T-cells for Immunologic Alternatives to Cancer Treatment. ICAART: PROCEEDINGS OF THE 12TH INTERNATIONAL CONFERENCE ON AGENTS AND ARTIFICIAL INTELLIGENCE, VOL 1. 10.5220/0008915601690178
Research highlights
PROJECTS
11 Ongoing projects
2 Ongoing clinical trials
PUBLISHED WORKS
1 Ongoing thesis
Selected projectes
- PLEIO-RANK:Pleiotropic treatment of cancer: RANK inhibitors targeting cancer stem cells and immunity (2016 – 2021) PI: GONZALEZ SUAREZ, EVA. Funder: COMUNITAT EUROPEA.
- Nuevos avances en el estudio de la vía de RANK en cáncer de mama: de la biología al tratamiento (2018 – 2020) PI: GONZALEZ SUAREZ, EVA. Funder: MINISTERIO DE EDUCACION Y CIENCIA.
- RANK, instead of RANKL, as a new therapeutic target in Triple Negative Breast Cancer (2019 – 2021) PI: GONZALEZ SUAREZ, EVA. Funder: ASOCIACION ESPAÑOLA CONTRA EL CANCER.
- Ayudas Juan de la Cierva – Incorporacion 2017 (2018 – 2020) PI: GONZALEZ SUAREZ, EVA. Funder: MINISTERIO DE EDUCACION Y CIENCIA.
- Contratos Rio Hortega (2020 – 2022) PI: GONZALEZ SUAREZ, EVA. Funder: FIS-Instituto de Salud Carlos III.